Menu
Search
|

Menu

Close
X

Avid Bioservices Inc CDMO.OQ (NASDAQ Stock Exchange Capital Market)

5.71 USD
-0.02 (-0.35%)
As of Oct 19
chart
Previous Close 5.73
Open 5.71
Volume 69,861
3m Avg Volume 179,850
Today’s High 5.78
Today’s Low 5.66
52 Week High 8.40
52 Week Low 2.25
Shares Outstanding (mil) 45.10
Market Capitalization (mil) 151.07
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY19
13
FY18
54
FY17
58
FY16
44
FY15
27
EPS (USD)
FY19
-0.061
FY18
-0.647
FY17
-0.571
FY16
-0.200
FY15
-2.082
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.65
Price to Sales (TTM)
vs sector
1.91
5.82
Price to Book (MRQ)
vs sector
2.70
4.89
Price to Cash Flow (TTM)
vs sector
--
22.93
Total Debt to Equity (MRQ)
vs sector
0.00
17.17
LT Debt to Equity (MRQ)
vs sector
0.00
12.75
Return on Investment (TTM)
vs sector
-36.53
14.28
Return on Equity (TTM)
vs sector
-48.18
16.00

EXECUTIVE LEADERSHIP

Roger Lias
President, Chief Executive Officer, Since 2017
Salary: --
Bonus: --
Daniel Hart
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Stephen Hedberg
Chief Accounting Officer, Since 2018
Salary: --
Bonus: --
Mark Ziebell
Vice President, General Counsel, Corporate Secretary, Since 2012
Salary: $348,000.00
Bonus: $91,350.00
Shelley Fussey
Vice President - Intellectual Property, Since 2005
Salary: $321,000.00
Bonus: $56,175.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2642 Michelle Dr Ste 200
TUSTIN   CA   92780-7019

Phone: +1714.5086100
Site: avidbio.com/

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides a variety of process development activities, including cell line development and optimization.

SPONSORED STORIES